Matching slides 41,369
Current window 31,831-31,860
Pages 1,379
Rows per page 30
Component: Calloutclear collectionreset all

Component

31,831-31,860 of 41,369

filter-aware
18
Mentions Organon as the commercial partner leveraging the NEXPLANON sales team.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
The slide highlights a key partnership milestone and the associated financial structure (upfront payment and potential milestones).Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
23
Includes a line chart of population projections and three circular callouts detailing specific product sales.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
27
Includes details on milestone payments, royalties, and strategic support from Bayer.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
28
Includes a testimonial quote from a Bayer executive.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
29
Includes a data table comparing baseline PCT results with Ovaprene PCT results.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
33
The slide uses a light blue callout box to group the product benefits and highlights the lack of current FDA-approved treatments for FSAD.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
37
Study design is a small N=6 crossover trial.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
40
The slide frames the market opportunity and clinical need for a non-oral hormone therapy.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
43
Dare Bioscience | Investor Presentation Deck | 54 slidesDare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
45
The slide highlights the clinical need for non-daily dosing progesterone delivery systems.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
46
The slide highlights a specific clinical need for breast cancer survivors.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
49
Includes regulatory disclaimer and multiple source citations.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
50
The slide uses a comparative framework to highlight the competitive advantage of the proposed product over the incumbent Depo-Provera.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
52
The slide uses a callout box to highlight the mechanism and benefits of GML.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
53
The slide highlights the clinical need for vaginal health solutions and the specific technical challenge of maintaining microbe viability in low-resource settings.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
08
The slide uses a stacked bar chart to visualize the composition of the $5.5B savings target.Disney | Results Presentation Deck | 30 slides · Disney
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
18
The slide highlights a $400 million improvement in operating losses in Q1'23 compared to the prior quarter.Disney | Results Presentation Deck | 30 slides · Disney
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
17
The slide uses a table to reconcile share counts from 2020 to 2024E, highlighting the impact of various activities on share dilution.DraftKings | Results Presentation Deck | 18 slides · DraftKings
Conference presentation Investor relations Beat · Resolution1 hit
14
The slide uses a grouped bar chart format to show year-over-year changes in expense categories.eBay | Results Presentation Deck | 34 slides · eBay
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
03
HSBC | Investor Presentation Deck | 12 slidesHSBC | Investor Presentation Deck | 12 slides · HSBC
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Before After1 hit
21
The scatter plot shows a high R-squared value of 0.9029, indicating a strong linear relationship between system placements and consumables revenue.Hydrafacial | Results Presentation Deck | 32 slides · BeautyHealth
Conference presentation Investor relations Beat · Action1 hit
06
The slide uses a 5-column icon-based layout to define investment criteria.Kinnevik | Investor Event Presentation Deck | 14 slides · Kinnevik
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The matrix uses a forest background; companies are placed as labels within the quadrants.Kinnevik | Investor Event Presentation Deck | 14 slides · Kinnevik
Conference presentation Investor relations 1 hit
11
The slide uses a forest background image with overlayed text and images of the facility and founders.Kinnevik | Investor Event Presentation Deck | 14 slides · Kinnevik
Conference presentation Investor relations 1 hit
05
The chart uses a grouped bar structure to compare private company performance (colored bars) against public comps (gray bars).Kinnevik | Results Presentation Deck | 20 slides · Kinnevik
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
08
The chart shows a bridge from a 54% average write-down to a 23% net impact after adjustments.Kinnevik | Results Presentation Deck | 20 slides · Kinnevik
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
13
The chart uses a 100% stacked bar format to show the shift in portfolio allocation over time.Kinnevik | Results Presentation Deck | 20 slides · Kinnevik
Conference presentation Investor relations Beat · DevelopmentLoop · Before After1 hit
15
The slide uses a circular icon-based layout to represent financial flows.Kinnevik | Results Presentation Deck | 20 slides · Kinnevik
Conference presentation Investor relations Beat · DevelopmentLoop · Before After1 hit
16
The slide highlights strong performance in Healthcare and Software, with a negative return in Platforms & Marketplaces.Kinnevik | Results Presentation Deck | 20 slides · Kinnevik
Conference presentation Investor relations Beat · DevelopmentLoop · Before After1 hit